People who receive certain blood products are recommended to receive hepatitis B vaccine

The following groups are recommended to receive hepatitis B vaccine because of their increased risk of infection through blood products:¹⁵

• people with clotting disorders who receive blood product concentrates
• people with recurrent transfusion requirements
• people with underlying immunocompromising conditions who receive blood products 

All blood donors in Australia are screened for hepatitis B using tests for hepatitis B surface antigen and nucleic acid amplification. This has greatly decreased the incidence of transfusion-related hepatitis B virus infection. 

Adult-formulation hepatitis B vaccine should be given in a 3-dose schedule. See Table. Monovalent hepatitis B vaccines for adolescents and adults in Vaccines, dosage and administration.